MoonLake Immunotherapeutics (MLTX) had a big drop because 1 out of 2 trials did not meet the expected topline results. The results were still positive overall, but there was a massive sell-off, which then led to retail traders wanting to take them to court for what they perceived as misinformation. Analysts were still positive regarding this stock, which reinforced the decision to enter the stock, and with how much the stock had dropped, the only way was up.
$MLTX
+99.9%
MoonLake Immunotherapeutics (MLTX)
+99.9%
Profit
in 211 days
Why did we enter?
What was happening?
Sudden stock drop of over 90% due to poor results, which essentially wiped out around $5 billion in market cap.
What we did
Sent out an alert to our premium members that I was entering the stock with an explanation as to why. An alert was later sent out of my exit.
Trade Details
Alert Date
10/13/2025
Entry Price
$9.73
Exit Price
$19.45
Profit Per Share
$9.72
Exit Date
05/12/2026
Time to Profit
211 days
Analyst
Peter
Security Manager
About Peter
Peter proves that your day job can become your biggest trading edge. Peter is a Mental ...